In general, has-miR-200c-5P overexpression in esophageal cancer increases resistance to chemotherapeutic drugs by dysregulating PI3K–Akt signaling pathway (Karakatsanis et al., 2013). The gene discussed is AKT1; the disease is esophageal cancer.